Kathleen S. Buaron
GlaxoSmithKline (United Kingdom)(GB)GlaxoSmithKline (India)(IN)GlaxoSmithKline (Japan)(JP)Respiratory Clinical Trials(AU)GlaxoSmithKline (Spain)(ES)
Publications by Year
Research Areas
Asthma and respiratory diseases, Respiratory and Cough-Related Research, Smoking Behavior and Cessation, Antimicrobial Resistance in Staphylococcus, Eating Disorders and Behaviors
Most-Cited Works
- → Bupropion SR vs. Placebo for Weight Loss in Obese Patients with Depressive Symptoms(2002)207 cited
- → Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone(2016)155 cited
- → Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo‐controlled study(2001)145 cited
- → Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma(2016)135 cited
- → LATE-BREAKING ABSTRACT: Safety of salmeterol/fluticasone propionate (FSC) compared to fluticasone propionate (FP) in 4-17 yr olds with asthma(2016)1 cited
- → COMPARATIVE EFFECTS OF CEFTAZIDIME TWO OR THREE TIMES DAILY IN PATIENTS WITH SKIN AND SKIN STRUCTURE INFECTIONS(1996)1 cited